Why stock in this Gaithersburg biotech is up more than 25 percent
The share price of Gaithersburg-based Emergent BioSolutions Inc. remains up more than 25 percent this week after announcing Dec. 8 it scored federal deals worth up to $1 billion to supply the Strategic National Stockpile for millions of doses of its anthrax vaccine.
Emergent (NYSE: EBS) was awarded the contract with the Centers for Disease Control worth up to $911 million for 29.4 million doses of BioThrax through 2021. The company also received a separate notice that the Biomedical Advanced Research…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Tina Reed Source Type: news
More News: American Health | Anthrax | Anthrax Vaccine | Biotechnology | Contracts | Health Management | Vaccines